Prof. Dr. Volkan Gürkan

Giant Cell Bone Tumor

Giant Cell Bone Tumor

What is giant cell bone tumor? Information about its symptoms, diagnostic methods, surgical treatment options, and post-operative follow-up process.

Giant cell bone tumors, although generally considered benign, can exhibit aggressive behavior in the areas where they occur. These tumors, which can cause expansion and damage to bone tissue, are particularly common in young and middle-aged adults who have completed skeletal development.

Giant cell bone tumors frequently develop in the femur (thigh bone) and tibia (shin bone) around the knee. They can also occur in the wrist and other bones. The disease can manifest with bone pain, swelling, limited joint movement, and in some cases, fractures due to bone weakening.

These tumors, which are generally non-cancerous, can rarely metastasize to the lungs. Therefore, careful planning of diagnosis, treatment, and follow-up processes is crucial.

Diagnosis and Evaluation

The evaluation of giant cell bone tumors involves considering the patient's complaints, physical examination findings, and radiological examinations together.

Imaging methods such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) scans can be used to assess the tumor's location within the bone, its size, and its relationship with surrounding tissues.

A biopsy and pathological examination are usually required for a definitive diagnosis. Additional investigations to assess the extent of the disease may be planned if necessary.

Treatment Approaches

The primary treatment approach for giant cell bone tumors is usually surgery. The treatment method is determined by the size and location of the tumor, the damage it has caused to the bone tissue, and the patient's clinical condition.

In surgical treatment, curettage to remove the tumor tissue is frequently preferred. The resulting bone cavity can be filled with bone graft or bone cement in suitable patients.

In cases where the bone and joint structure are severely affected, more extensive tumor resection and reconstruction methods may be necessary.

In selected patients for whom surgery is unsuitable or may lead to significant functional loss, drug therapies such as denosumab may be evaluated in a multidisciplinary manner.

Since giant cell bone tumors can recur after treatment, regular clinical and radiological follow-up is important.